遠丰醫旅 https://healer.tw/en/ 生命的意義在於體驗感覺 每一刻都值得精彩紀念 Wed, 05 Aug 2026 07:07:11 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 https://healer.tw/wp-content/uploads/2024/06/cropped-favicon-32x32.png 遠丰醫旅 https://healer.tw/en/ 32 32 Healer Medical Travel Partners with U.S. Biotech to Expand Health Management Options for Patients with Blood Sugar Concerns https://healer.tw/en/uncategorized/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%e6%94%9c%e6%89%8b%e7%be%8e%e5%9c%8b%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%ef%bc%8c%e6%8f%90%e5%8d%87%e8%a1%80%e7%b3%96%e6%82%a3%e8%80%85%e5%81%a5%e5%ba%b7%e7%ae%a1/ Sun, 24 Nov 2024 23:02:33 +0000 https://healer.tw/%e6%9c%aa%e5%88%86%e9%a1%9e/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%e6%94%9c%e6%89%8b%e7%be%8e%e5%9c%8b%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%ef%bc%8c%e6%8f%90%e5%8d%87%e8%a1%80%e7%b3%96%e6%82%a3%e8%80%85%e5%81%a5%e5%ba%b7%e7%ae%a1/ Press Release

 

Taipei, October 2024 — Healer Medical Travel announced a partnership agreement with a well-known U.S. biotechnology company to introduce its natural health product into the Taiwan medical market. Formulated with pure natural ingredients, the product focuses on protecting and promoting the healthy regeneration of pancreatic pancreatic β-cells. Through the introduction of this product, the company aims to provide a brand-new, comprehensive health management solution for patients seeking blood sugar management.

 

Under this collaboration, Healer Medical Travel actively integrates local medical resources in Taiwan, partnering with Formosa Biomedical iHealth Clinic to establish a blood sugar management consultation clinic. This allows patients to receive health management and promotion plans through a professional medical network service, helping them improve their health conditions through convenient medical channels.

Healer Medical Travel has long been committed to introducing cutting-edge international medical technologies and products to provide patients in Taiwan with more diverse health management choices. This collaboration fully leverages Healer Medical Travel’s strengths in cross-border medical cooperation, creating new opportunities for patients through synergy with Taiwanese medical institutions. Through the introduction of this product, Healer Medical Travel looks forward to making positive contributions to chronic disease health management and enhancing patients’ quality of life.

About Healer Medical Travel
Healer Medical Travel focuses on seeking cutting-edge treatment solutions for patients and is dedicated to integrating global resources to offer diverse services covering both medical care and health management. Possessing extensive experience in international medical collaboration, the company works closely with world-leading experts and institutions to provide optimal health management solutions for patients.

 

For more information, please contact:
Healer Medical Travel Public Relations Department
365@healer.tw
Cindy

]]> Healer Medical Joins Hands with More Health to Expand Cross-Border Medical Cooperation and Support Patients with Critical Illnesses https://healer.tw/en/latest-news/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%e6%94%9c%e6%89%8bmore-health%ef%bc%8c%e6%8b%93%e5%b1%95%e8%b7%a8%e5%9c%8b%e9%86%ab%e7%99%82%e5%90%88%e4%bd%9c-%e5%8a%a9%e5%8a%9b%e9%87%8d%e5%a4%a7%e7%96%be/ Mon, 18 Nov 2024 00:42:59 +0000 https://healer.tw/%e6%9c%aa%e5%88%86%e9%a1%9e/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%e6%94%9c%e6%89%8bmore-health%ef%bc%8c%e6%8b%93%e5%b1%95%e8%b7%a8%e5%9c%8b%e9%86%ab%e7%99%82%e5%90%88%e4%bd%9c-%e5%8a%a9%e5%8a%9b%e9%87%8d%e5%a4%a7%e7%96%be/ TAIPEI, November 18, 2024 — Healer co., Ltd (Healer Medical Travel) announced today that it has officially entered into a strategic partnership with More Health, a renowned international medical services company. Together, they aim to provide patients with critical illnesses comprehensive cross-border diagnosis and treatment, as well as precision medical services. Through this collaboration, Healer Medical Travel will integrate top-tier global medical resources, enhance treatment efficacy, and deliver more flexible and convenient healthcare solutions for patients and their families.

 

Innovative Collaboration to Support Patients with Critical Illnesses

 

More Health has long been dedicated to providing patients worldwide with professional medical consultations and second opinions, leveraging extensive clinical experience and an international network of experts. Partnering with More Health enables Healer Medical Travel to introduce diagnostic recommendations from more than 10,000 top global physicians and specialists. Furthermore, it assists patients with cross-border referrals, treatment plan optimization, and rehabilitation services—offering all-around support for those suffering from major health conditions, such as cancer and chronic diseases.

 

Integrating International Expert Resources to Build Premium Medical Services

 

Relying on More Health’s global network of specialists, Healer Medical Travel will offer tailored medical services based on individual patient needs. These services include medical evaluations, second opinion consultations, surgical arrangements, and post-operative care. Patients can access More Health’s professional services through Healer Medical Travel, ensuring that every medical decision is backed by legitimate international experts.

 

Enhancing Patient Experience to Achieve True Precision Medicine Freedom

 

Healer Medical Travel has long been committed to providing patients with a person-centered medical travel experience. Through this partnership, patients can overcome geographical barriers and receive treatment plans best suited to their conditions. Healer Medical Travel’s services also encompass end-to-end medical travel arrangements, helping patients seamlessly secure appointments with top-tier physicians and achieve the goal of precision medicine.

 

The founder of Healer Medical Travel stated: “This collaboration represents a major milestone in fulfilling Healer’s vision for globalized healthcare. We believe that combining More Health’s professional capabilities with our deep understanding of patient needs will bring health benefits to more patients and assist them on their path to recovery.”

 

About Healer Medical Travel

 

Healer Medical Travel is a company specializing in cross-border medical travel and health management. It is dedicated to providing Asian and global patients with high-quality medical consultations, specialist diagnosis and treatment, and rehabilitation support. By collaborating with numerous international medical institutions and expert teams, the company seeks out the optimal treatment plans for patients with critical illnesses while offering thoughtful medical travel services to help patients enjoy top global medical resources worry-free.

 

about More Health

 

About More Health
More Health is a leading international medical service platform that possesses top physician resources across the United States. It is dedicated to providing medical consultations and second opinions through its global expert network, as well as helping patients develop personalized treatment plans. More Health aims to offer convenient, professional, and reliable medical support to patients worldwide, ensuring they receive the most appropriate diagnostic and treatment recommendations during critical illness care.

]]> Healer Medical Travel: Building a Bridge to Health, Opening New Treatment Opportunities for Patients with Cholangiocarcinoma and Peritoneal Metastasis https://healer.tw/en/latest-news/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%ef%bc%9a%e6%90%ad%e8%b5%b7%e5%81%a5%e5%ba%b7%e6%a9%8b%e6%a8%91%ef%bc%8c%e7%82%ba%e8%86%bd%e7%ae%a1%e7%99%8c%e5%90%88%e4%bd%b5%e8%85%b9%e8%86%9c%e8%bd%89%e7%a7%bb/ Tue, 27 Aug 2024 09:51:13 +0000 https://healer.tw/%e6%9c%aa%e5%88%86%e9%a1%9e/%e9%81%a0%e4%b8%b0%e9%86%ab%e6%97%85%ef%bc%9a%e6%90%ad%e8%b5%b7%e5%81%a5%e5%ba%b7%e6%a9%8b%e6%a8%91%ef%bc%8c%e7%82%ba%e8%86%bd%e7%ae%a1%e7%99%8c%e5%90%88%e4%bd%b5%e8%85%b9%e8%86%9c%e8%bd%89%e7%a7%bb/ Healer Medical Travel: Building a Bridge to Health, Opening New Treatment Opportunities for Patients with Cholangiocarcinoma and Peritoneal Metastasis

 

Taipei, 2024 — Healer Medical Travel (HEALER.TW) provides comprehensive medical coordination management services and cross-border medical assistance for patients with cholangiocarcinoma and peritoneal metastasis. In 2024, Healer Medical Travel successfully coordinated international expert resources to seek a potentially breakthrough therapy for a patient—Recombinant Human p53 Adenovirus Injection. Developed by a Chinese pharmaceutical company, this therapy is gradually becoming a new treatment option for patients with this type of cancer.

 

Multi-Expert Consultation: Cross-Border Collaboration Enhances Communication Outcomes

 

Coordinated by Healer Medical Travel, this collaboration brought together Dr. Ben-Ren Lin, a U.S. proteomics expert, and Taiwanese oncology professors. Combining cutting-edge cancer research with clinical expertise, they discussed an integrated treatment plan targeting the therapeutic challenges of cholangiocarcinoma with peritoneal metastasis. The plan focuses not only on slowing cancer progression, but also on improving the patient’s overall quality of life.

 

Integrating Medical and Travel Services to Give Patients a New Lease on Life

 

Healer Medical Travel offers more than just treatment assistance; it provides comprehensive professional medical consulting services. From pre-treatment consultation and diagnosis to the formulation and execution of cross-border treatment plans, Healer Medical Travel assists patients in fully integrating international medical services to ensure they receive care in the optimal environment. Catering to medical travel services with high professional demands, it provides customized management services that offer great convenience and confidence to patients and their families.

 

Healer Medical Travel Network: Professional Coordination to Safeguard Health

 

During this expert consultation and treatment collaboration, the Healer Medical Travel network played a pivotal role. Leveraging its extensive professional medical resources and international connections, the network provided end-to-end coordination and support for the patient and their family. Services included obtaining expert opinions, dispatching air ambulances, fast-track customs courtesy, priority medical channels, and medical advance payment services—ensuring every step was executed with precision so the patient could complete treatment smoothly.

 

About Healer Medical Travel

 

Since its inception, Healer Medical Travel has been dedicated to providing professional medical tourism services to global patients. Leveraging its unique cross-border collaboration capabilities and expert resources, the company helps numerous patients find optimal treatment solutions. Healer Medical Travel believes that through professional coordination and management, it can build a new bridge to health for patients.

 

Media Contact

 

Yuan Feng Medical Travel

Contact Person: [CindyHuang]

Phone: [+886 2 8286-6876]

EMAIL: [365@healer.tw]

 

—

 

This press release aims to highlight the crucial role played by Healer Medical Travel in seeking new treatment opportunities for patients with cholangiocarcinoma and peritoneal metastasis, as well as its leading position in international medical collaboration.

]]> Medical Information https://healer.tw/en/medical-information/medical-information/ Thu, 07 Dec 2023 07:31:45 +0000 https://healer.tw/uncategorized/medical-information/ Taipei Veterans General Hospital (TVGH) inaugurated its heavy ion therapy facility on May 15 this year, completing treatment for 100 patients within six months as of today (Dec. 5). TVGH Superintendent Chen Wei-ming noted that pancreatic cancer—previously considered untreatable—can now be surgically removed following chemotherapy and heavy ion therapy. Other conditions, including prostate, lung, liver, bone and soft tissue sarcoma, head and neck, and gynecological cancers, have also been successfully treated.

 

Taipei Veterans General Hospital (TVGH) held a Thanksgiving Ceremony today to mark two major clinical milestones: achieving 100 heavy ion therapy cases and completing 5,000 Robotic-Assisted Da Vinci surgeries. The event also featured a ribbon-cutting ceremony for Taiwan’s first high-tech negative-pressure ICU and the launch of the “TVGH No. 1 Cloud” supercomputer. Veterans Affairs Council Minister Feng Shih-kuan attended the event, commending the TVGH team led by Superintendent Chen Wei-ming for their exceptional achievements in cancer treatment, critical care epidemic prevention, and smart healthcare to benefit patients. He encouraged the entire TVGH healthcare system to continue working together to deliver high-quality medical services.

 

“A patient’s life is priceless. Seeing critically ill patients recover makes everything worth it,” said Chen Wei-ming. He noted that Taipei Veterans General Hospital (TVGH) built the heavy ion therapy center despite the operational losses it would incur. Currently, the treatment process is proceeding smoothly, with patients making good recoveries and their long-term outcomes being continuously monitored. With many candidates still on the waiting list, the operating center has drawn a steady stream of visiting delegations from around the world.

 

Chen Wei-ming also expressed his gratitude to the entire TVGH staff for their unit, solidarity, and collaborative efforts in presenting these remarkable achievements at the end of the year. Beyond heavy ion therapy, Taipei Veterans General Hospital (TVGH) has completed 5,000 robotic-assisted Da Vinci surgeries, including challenging cancer procedures such as pancreatic cancer, periampullary cancer, and partial nephrectomy for renal cancer. Currently, TVGH holds the highest case volume nationwide for Da Vinci procedures in these three conditions. Furthermore, the broader Veterans Affairs Council healthcare system has collectively performed nearly 12,000 Da Vinci surgeries.

 

Today also saw the inauguration of “TVGH No. 1 Cloud”—Taiwan’s first clustered supercomputing platform custom-designed for a hospital. Powered by next-generation AI processing capabilities, a robust data center, and innovative computing architecture, the platform aims to advance medical applications of generative AI and Large Language Models (LLMs).

 

“TVGH No. 1 Cloud” significantly enhances overall computing capacity, accelerating the hospital’s progress in precision medicine, smart healthcare, disease prognosis prediction, genomic sequence analysis, digital pathology precision diagnosis, and AI-driven drug discovery. Furthermore, it serves as an optimal development platform for AI applications.

 

Chen Wei-ming noted that this not only enhances diagnostic precision but also accelerates the formulation of personalized treatment strategies for various diseases. This marks not only a major milestone in TVGH’s IT development, but also a significant step forward for Taiwan in high-performance computational medicine. Furthermore, it opens new avenues for international medical collaboration, further driving innovation and development in medical AI.

 

In response to future emerging infectious diseases, Taiwan’s first smart-tech Intensive Care Unit (ICU) has been launched at Taipei Veterans General Hospital (TVGH). TVGH invested over NT$100 million to construct 15 smart negative-pressure isolation ICU beds in its Technology Building, which is structurally separated from the main inpatient buildings to ensure compartmentalization. The facility integrates cutting-edge and self-developed technologies—including an AI smart mirror for PPE donning and doffing guidance and a hand hygiene monitoring system—which have earned recognition from the National Healthcare Quality Award. Additionally, satellite nursing stations facilitate remote image monitoring and ventilator adjustments, while smart TVs and three-way video communication systems are installed. Robots are also deployed to assist nurses with supply transport, minimizing infection exposure risks for medical personnel.

 

During epidemic outbreaks, this facility provides negative-pressure isolation intensive care under the highest infection control standards; during normal operations, it functions as a respiratory intensive care unit for general critical care. This approach achieves five key objectives: “blocking the virus, transmitting signals out, delivering medical care in, connecting care partners, and keeping family members visually connected”—thereby significantly enhancing the quality of critical care. Furthermore, multiple advanced technological innovations, including smart robots, elevate both care quality and infection control safety.

 

 

Source: United Daily News, Dec. 6, 2023 / Reported by Shen Neng-yuan, Taipei

TVGH Superintendent Chen Wei-ming pointed out that life is priceless, and that seeing critically ill patients find hope after Taipei Veterans General Hospital built its heavy ion therapy center makes everything worth it. Photo / Provided by Taipei Veterans General Hospital

]]> Heavy Ion Cancer Therapy Costs Millions with High Demand; Taipei Veterans General Hospital Shows Prominent Success in Pancreatic Cancer Treatment https://healer.tw/en/medical-information/heavy-ion-cancer-therapy-costs-millions-with-high-demand-taipei-veterans-general-hospital-shows-prominent-success-in-pancreatic-cancer-treatment/ Thu, 07 Dec 2023 07:28:26 +0000 https://healer.tw/uncategorized/heavy-ion-cancer-therapy-costs-millions-with-high-demand-taipei-veterans-general-hospital-shows-prominent-success-in-pancreatic-cancer-treatment/ Taipei Veterans General Hospital launched its heavy ion therapy service on May 15 this year, completing treatment for 100 patients within six months as of today (12/5). According to stats from the hospital, the top four cancers treated with heavy ion therapy over the past six months are prostate cancer, pancreatic cancer, liver cancer, and lung cancer—with prostate and pancreatic cancers each accounting for one-third of cases, and pancreatic cancer showing the best results. The current approach for treating pancreatic cancer combines heavy ion therapy with chemotherapy, offering patients who were originally unsuitable for surgery a chance to shrink their tumors enough for surgical resection.

Li Wei-chiang, Vice President of Taipei Veterans General Hospital, noted that because the pancreas is located deep within the body, pancreatic cancer is difficult to detect early and is often diagnosed at Stage IV. At this stage, the tumor has typically adhered to surrounding blood vessels and tissues, rendering surgery impossible. Furthermore, conventional radiation therapy can easily cause complications, making treatment exceptionally difficult, ineffective, and associated with a high mortality rate.

Taipei Veterans General Hospital established the “Pancreatic Cancer Treatment and Research Center” in August this year. Li Wei-chiang pointed out that current pancreatic cancer treatment utilizes heavy ion therapy combined with chemotherapy, which has successfully detached tumors from surrounding blood vessels and tissues in several patients to facilitate subsequent surgery. Multiple patients have already received treatment, with Li stating, “This is what brings me the greatest joy.”

Currently, the number of pancreatic cancer patients receiving heavy ion therapy at Taipei Veterans General Hospital ranks second, behind only prostate cancer. When Japanese experts visited Taipei VGH recently and learned about these pancreatic cancer treatment outcomes, they were deeply impressed.

Li Wei-chiang noted that many cancer patients view heavy ion therapy as their last ray of hope, with a significant number being referred from other hospitals. In response, Taipei VGH has added special outpatient clinics to evaluate patients’ conditions as quickly as possible. Heavy ion therapy at Taipei VGH requires a varying number of treatment sessions per course depending on the type of cancer—for instance, pancreatic cancer and prostate cancer each require 12 sessions. Each full treatment course costs approximately NT$1 million to NT$1.5 million out-of-pocket, and most patients are over 60 years old.

Heavy ion therapy is an out-of-pocket treatment. For cancer patients who do not meet the treatment criteria, the hospital strictly screens candidates and refers them to relevant departments for appropriate care, preventing patients from spending money unnecessarily on unsuitable therapy. Li Wei-chiang noted that many breast cancer patients visit the heavy ion outpatient clinic seeking treatment; however, since effective medications covered by National Health Insurance are currently available for breast cancer, the hospital declines these requests even if patients are willing to pay out-of-pocket, as patient well-being must come first.

Li Wei-chiang noted that heavy ion therapy is costly and recalled that at the time of its opening in May, the hospital pledged to reserve 2% of its capacity annually to treat underprivileged patients free of charge. Currently, one eligible candidate from a disadvantaged background has submitted an application. A meeting will be held this Friday to review the patient’s medical condition and evaluate whether heavy ion therapy is suitable. As a public hospital, Taipei VGH remains committed to fulfilling its promise and upholding its responsibility to care for public health.

 

Source:

2023-12-06 23:21 聯合報／ 記者沈能元／台北即時報導

]]> Single-Stage Cartilage Repair Surgery: Say Goodbye to Degeneration and Welcome a New Life https://healer.tw/en/medical-information/single-stage-cartilage-repair-surgery-say-goodbye-to-degeneration-and-welcome-a-new-life/ Wed, 15 Mar 2023 05:08:54 +0000 https://healer.tw/uncategorized/single-stage-cartilage-repair-surgery-say-goodbye-to-degeneration-and-welcome-a-new-life/  

RevoCart Surgery Services

 

Description:
  • RevoCart surgery service is a minimally invasive procedure that utilizes autologous cartilage processed through physical and chemical treatment to activate chondrocytes, combined with a bioresorbable biphasic scaffold (mimicking cartilage and subchondral bone).
  • Implanted via arthroscopy or a minimally invasive incision, it enables cartilage regeneration and repair. The procedure takes approximately 1 to 2 hours, and patients can typically be discharged 1 to 2 days post-surgery.
  • The RevoCart team conducted clinical trials in Taiwan, with its efficacy and safety certified by the Ministry of Health and Welfare (MOHW). Follow-up data spanning approximately ten years demonstrates that post-operative joint pain is significantly relieved, quality of life is enhanced, and patient satisfaction remains high.
Features:
  • Single-stage, minimally invasive procedure with small incisions.
  • Regenerated cartilage is structurally similar to native cartilage.
  • Extends the lifespan of your natural joint.
  • Allows a return to high-intensity sports and exercise after recovery.
Symptoms:
  • * Pain caused by cartilage and subchondral bone defects.
  • Early-stage osteoarthritis (without severe mechanical axis alignment deviation).
Target Area:
  • knee
  • Talus
Rehabilitation Services:
  • Post-operative rehabilitation is required.
  • Initially practice partial weight-bearing post-surgery, gradually increasing weight load as pain subsides. Use of a knee brace and assistive devices is recommended, alongside joint range-of-motion stretching exercises to stimulate cartilage regeneration and repair.
Outpatient Care Process:
  1. Outpatient Consultation
  2. MRI Examination
  3. Surgical Scheduling (Inpatient Required)
  4. Home-based Rehabilitation
How to Schedule a Consultation:
  • Contact us sultants to learn more about medical care and treatment services. Feel free to join Far East Medical Tourism for a consultation.

    LINE@:

    https://lin.ee/imkgrLh

Healer Green Channel Service:
  • Priority Outpatient Appointment Assistance
  • Personalized Medical Escort Service
  • Post-operative Rehabilitation Arrangements
Outpatient Consultation
  • Postal Hospital
  • Taipei Veterans General Hospital
  • Tri-Service General Hospital Neihu Main Branch
  • Tri-Service General Hospital Keelung Branch
  • Zhongshan Hospital
  • Taipei Medical University Hospital
  • Wanfang Hospital
  • Shuang Ho Hospital
  • Taipei Tzu Chi Hospital
  • En Chu Kong Hospital
  • Fu Jen Catholic University Hospital
  • Taoyuan Armed Forces General Hospital
  • Changhua Christian Hospital
  • Taichung Veterans General Hospital
  • An Nan Hospital
  • National Cheng Kung University Hospital
  • Sinlau Hospital
  • Asia University Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital

 

 

 

 

 



 

]]>
					
		
		
			
		
		Taiwan’s First “Exablate” Case Relieves Parkinson’s Tremor Symptoms!
		https://healer.tw/en/medical-information/taiwans-first-exablate-case-relieves-parkinsons-tremor-symptoms/
		
		
		Sat, 25 Feb 2023 11:22:12 +0000
				
		https://healer.tw/uncategorized/taiwans-first-exablate-case-relieves-parkinsons-tremor-symptoms/

					
										Taiwan’s First Exablate Case Relieves Parkinson’s Tremor Symptoms!

In November 2018, the Exablate Center performed a treatment to relieve symptoms in a patient suffering from Parkinson’s tremors. Post-surgery, the patient’s resting tremor in the left hand was successfully alleviated. Now, when dining out and joining social gatherings, they can finally feel more confident and no longer fear drawing unwanted attention!





]]>
					
		
		
			
		
		Loss of Appetite Turn Out to Be Pancreatic Cancer: Concurrent Proton and Chemotherapy Achieves a Turnaround!
		https://healer.tw/en/medical-information/loss-of-appetite-turn-out-to-be-pancreatic-cancer-concurrent-proton-and-chemotherapy-achieves-a-turnaround/
		
		
		Sun, 26 Feb 2023 02:38:10 +0000
				
		
		
		
		https://healer.tw/uncategorized/loss-of-appetite-turn-out-to-be-pancreatic-cancer-concurrent-proton-and-chemotherapy-achieves-a-turnaround/

					
										

Loss of Appetite Turn Out to Be Pancreatic Cancer: Concurrent Proton and Chemotherapy Achieves a Turnaround!


In October last year, 57-year-old Ms. Chen suffered from a loss of appetite, losing nearly 10 kilograms within three months. After seeking medical attention at Taipei Veterans General Hospital, she was diagnosed with Stage III pancreatic cancer. However, because the tumor had already invaded major blood vessels, it could not be surgically removed. She then visited the Proton and Radiation Therapy Center at Linkou Chang Gung Memorial Hospital for a consultation to see if proton therapy could provide further treatment options.





During her consultation at the Department of Radiation Oncology with Director Chang Tung-Chieh, Ms. Chen and her family learned—thanks to Director Chang’s warm and professional explanation—that besides surgical treatment, pancreatic cancer can also be treated with concurrent chemoradiotherapy (concurrent radiation therapy and chemotherapy). However, conventional radiation therapy (photon therapy) is limited by its energy penetration depth, causing significant damage to the gastrointestinal tract. As a result, the radiation dose cannot be increased during conventional chemoradiotherapy, and chemotherapy often has to be halted due to side effects, making it difficult to achieve optimal efficacy. In contrast, proton therapy can lower the dose delivered to the gastrointestinal tract and reduce side effects, allowing a higher radiation dose to be delivered directly to the tumor for better therapeutic outcomes than conventional photon therapy. Consequently, Ms. Chen and her family decided to undergo concurrent proton therapy combined with chemotherapy.






Translation:
During the approximately one-and-a-half-month course of concurrent proton therapy and chemotherapy, Ms. Chen did not experience severe diarrhea or the need to halt treatment—issues commonly seen with conventional therapy. She had only mild diarrhea, which did not affect her overall nutritional status. As a result, the chemotherapy administered concurrently with proton therapy proceeded according to the original plan without any dose reductions or interruptions. Ms. Chen was also able to continue receiving consolidation chemotherapy following the concurrent proton and chemotherapy treatment, ultimately achieving the desired optimal therapeutic outcome.






Three months after completing proton therapy, Ms. Chen underwent a PET scan to evaluate the tumor’s response to treatment. The results showed complete local control with no metabolic activity detected. Subsequent CT scans revealed that the original tumor had shrunk from 4 cm to approximately 2 cm, indicating a favorable response and suggesting that the remaining mass is very likely residual scar tissue post-treatment. She will continue to be monitored closely.






Proton radiation therapy has brought hope for a cure to pancreatic cancer patients whose tumors were previously considered inoperable and left doctors with limited options. Utilizing the latest proton radiation therapy enables patients to achieve pain-free treatment, superior efficacy, and fewer side effects, thereby reversing their condition. In the future, we hope more patients can stage a successful comeback just like Ms. Chen!




]]>
					
		
		
			
		
		Inner Mongolia Man Finds New Life Through Proton Therapy After Post-Surgery Lung Cancer Metastasis
		https://healer.tw/en/medical-information/inner-mongolia-man-finds-new-life-through-proton-therapy-after-post-surgery-lung-cancer-metastasis/
		
		
		Sun, 26 Feb 2023 01:43:48 +0000
				
		
		
		
		https://healer.tw/uncategorized/inner-mongolia-man-finds-new-life-through-proton-therapy-after-post-surgery-lung-cancer-metastasis/

					
										

Inner Mongolia Man Finds New Life Through Proton Therapy After Post-Surgery Lung Cancer Metastasis


Just when a patient believes they have escaped the threat of death after undergoing difficult surgery, realizing that the disease is still lingering comes as the biggest shock. This situation is often the most agonizing for both the patient and the family supporting them through the ordeal.





Mr. Tang (pseudonym), a man in his 50s from Inner Mongolia, was once a typical optimistic nomad of the grasslands, blessed with a bold, clear, resonant voice and a bright, hearty smile. However, after being diagnosed with lung cancer during an examination in February 2016 and undergoing surgical resection, his originally bold and clear voice vanished completely, replaced by a raspy, low-pitched guttural sound that sent his spirits plummeting to rock bottom. Yet troubles came in succession—shortly after, his local doctor delivered another piece of bad news: the tumor site appeared not to have been cleanly excised, posing a risk of further spread and metastasis. Having barely survived the grueling surgery to save his life, Mr. Tang was immediately confronted with the fact that his life remained under threat; this double blow left him deeply despondent, looking utterly crestfallen and frail, which weighed heavily on his worried family.






After continuous searching for treatment options and consultations, Mr. Tang and his family decided a month later to fly nearly 2,000 kilometers to Taiwan’s Chang Gung Memorial Hospital for a comprehensive examination. Following a series of tests, including a bronchoscopy and CT scans, Dr. Kuo Han-pin from Chang Gung’s Division of Pulmonary and Critical Care Medicine evaluated that residual tumor tissue and partial metastasis were indeed present. However, because it had only been a short month since Mr. Tang’s surgery, and his post-operative hoarseness was quite severe, Dr. Kuo proceeded with utmost caution, concluding that chemotherapy combined with proton therapy should be administered first to stabilize his condition in order to achieve the best medical outcome.








In recent years, the development and application of proton therapy in cancer treatment have been rapidly expanding. The Proton and Radiation Therapy Center at Chang Gung Memorial Hospital opened in 2015, making it the largest proton therapy center in Asia. Its biggest difference compared to conventional photon therapy—the radiation therapy currently used by most hospitals—lies in the strong penetrative nature of photon beams, which are more likely to damage normal tissue behind the tumor site. In contrast to traditional radiation therapy using X-rays, proton therapy allows precise energy control, releasing a massive amount of energy at a specific depth while releasing minimal energy along its pathway. Furthermore, charged particles have a fixed depth of penetration, leaving zero radiation beyond the tumor area and drastically reducing damage to healthy surrounding tissue. For patients whose tumors are unsuitable for surgical removal, proton therapy lowers treatment risks, reduces distant radiation dosage, and significantly minimizes side effects, enabling patients to maintain a good quality of life throughout their course of treatment.






After deciding to receive treatment at Chang Gung Memorial Hospital, Mr. Tang traveled from Mongolia to Taiwan again in May 2016, undergoing a total of three weeks of chemotherapy and 12 sessions of proton therapy before returning to Inner Mongolia once his condition was confirmed to be stable. Half a year later, he returned to Taiwan’s Chang Gung Memorial Hospital for a follow-up examination. Follow-up CT scans confirmed that there was no tumor recurrence, though an inflammatory reaction was present at the site of the primary tumor. The medical team evaluated that the inflammation was a normal post-proton-therapy reaction and no cause for overconcern. They advised Mr. Tang to pay attention to daily self-care, including eating slowly and chewing thoroughly rather than taking large bites, as well as maintaining regular exercise and continuing his pulmonary medications, after which he would only need to return for routine follow-up checkups at scheduled intervals.






For patients with relatively advanced lung cancer that has not yet metastasized to distant sites, combined chemotherapy and radiation therapy currently offers the best therapeutic outcomes. Because larger tumors are often accompanied by lung collapse, which severely impacts a patient’s physical condition and quality of life, proton therapy can minimize radiation damage to the remaining lung tissue and preserve maximal lung function. Learning that his cancerous lesions had been successfully cleared left Mr. Tang with a deep appreciation for the precise diagnosis and high-standard care at Taiwan’s Chang Gung Memorial Hospital. Reflecting on his three medical trips to Taiwan, he shared that he was not only impressed by the hospital’s advanced facilities but also felt completely at ease throughout the process. Now, he and his family no longer live under a cloud of worry, thanks to the dedicated efforts of Dr. Kuo Han-pin and the medical team. Moving forward, he will continue regular follow-up checkups and focus on daily self-care in hopes of making a full recovery soon, wishing to sing freely once again on the vast grasslands.



]]>
					
		
		
			
		
		Prominent Lawyer Travels Abroad for Medical Care, Amazed to Find Proton Therapy Free from Damage Caused by Conventional Radiation
		https://healer.tw/en/medical-information/prominent-lawyer-travels-abroad-for-medical-care-amazed-to-find-proton-therapy-free-from-damage-caused-by-conventional-radiation/
		
		
		Sun, 26 Feb 2023 01:39:16 +0000
				
		
		https://healer.tw/uncategorized/prominent-lawyer-travels-abroad-for-medical-care-amazed-to-find-proton-therapy-free-from-damage-caused-by-conventional-radiation/

					
										

Xiao Chen (pseudonym), a 35-year-old male and a prominent lawyer from Malaysia, traveled to Taiwan for nasopharyngeal carcinoma treatment. Facing a second recurrence of nasopharyngeal carcinoma, he was cautious. Through online searches and extensive inquiries, he learned that Taiwan has vast experience treating nasopharyngeal carcinoma patients, rendering it almost as routine as managing a common cold. Furthermore, our hospital possesses proton therapy machines, a facility available in only a few Asian countries. Xiao Chen then provided our hospital with his relevant medical reports from his first nasopharyngeal carcinoma treatment in Malaysia—including pathology slides, whole-body PET scans, and initial photon therapy records. Accompanied by his wife and filled with hope, he traveled across the ocean to Taiwan Chang Gung Memorial Hospital seeking proton therapy.





Upon Xiao Chen’s arrival in Taiwan, our center immediately arranged outpatient consultations and relevant examinations with his specified physicians, Dr. Chang Tung-Chieh and chemotherapy specialist Dr. Hsieh Chia-Hsun. Following the recommendations of both physicians, Xiao Chen underwent a whole-body PET scan and blood tests once again to serve as baseline indicators for his proton therapy and chemotherapy. Dr. Chang Tung-Chieh, with an approachable and humorous tone, explained the re-irradiation treatment plan to Xiao Chen and his wife, who appeared strong on the surface. Dr. Chang recommended a combined regimen of 33 proton therapy sessions and 33 photon therapy sessions, paired with weekly chemotherapy concurrent with radiation therapy to achieve disease control. During the course of treatment, Xiao Chen experienced almost none of the skin discomfort typically caused by prolonged radiation exposure, which greatly surprised him. Based on his previous experience with photon therapy in Malaysia, severe radiation dermatitis at the irradiated site was quite common.






As his treatment in Taiwan drew to a close, the tumor on the inner side of Xiao Chen’s neck gradually shrank. By simply maintaining a normal daily routine and acquiring proper knowledge regarding medication, Xiao Chen will only need to monitor post-radiation side effects—including regular dental follow-ups—after returning to his home country. With a treatment outcome like this, who can say that a cancer recurrence is an incurable disease?






Proton radiation therapy is currently the world’s most advanced technique for tumor radiotherapy. Compared to conventional radiation therapy, proton radiation therapy causes significantly less damage to healthy cells surrounding the lesion site, resulting in fewer side effects. Many highly treatable tumors can achieve high cure rates through proton therapy (either alone or combined with surgery and chemotherapy). Beyond improving quality of life both during and after treatment, proton therapy also reduces the risk of developing secondary malignancies caused by the “low-to-moderate radiation doses” delivered to normal tissues in conventional radiotherapy.




]]>